Deadline: CEPI Call for Proposals – Vaccines Against Novel Coronavirus
CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. The call is open for two weeks until
CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. The call is open for two weeks until
PHEP Recipient Monthly Conference Call Scheduled for February 19 CDC’s next monthly conference call with PHEP recipients will be held from 3 p.m. to 4 p.m. EDT on Wednesday, February
Target Audience: Health care providers (including primary care physicians & nursing professionals) Key Note Speakers: Dr. Gerald Evans Chair of the Division of Infectious Diseases, Professor of Medicine, Queens University;
The capability to provide unburdened chem-bio protection will maximize time on target for the warfighter and the stability operator, provide operational flexibility, extend mission duration, and enable military operations in
The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the
A U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity will be held Feb 25-26, 2020 at the NIAID Conference Center
A planning committee of the National Academies of Sciences, Engineering, and Medicine will conduct a one day workshop on Feb 26, 2020 to bring together stakeholders to discuss potential ethical
The House Foreign Affairs Subcommittee on Asia, the Pacific, and Nonproliferation will hold a second subcommittee hearing on the coronavirus outbreak on 27 Feb 2020 at 2:00 Eastern. Witnesses will
HHS-NIH-NIAID-BAA2020-1 Research Area 002: Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated With Enterovirus D68 Supports the development of inactivated Enterovirus D68 vaccines, preferably using adjuvants that